Endothelin signaling is required for neural crest migration and homeostatic regulation of blood pressure. Here, we report that constitutive overexpression of Endothelin-2 (Edn2) in the mouse retina perturbs vascular development by inhibiting endothelial cell migration across the retinal surface and subsequent endothelial cell invasion into the retina. Developing endothelial cells exist in one of two states: tip cells at the growing front and stalk cells in the vascular plexus behind the front. This division of endothelial cell states is one of the central organizing principles of angiogenesis. In the developing retina, Edn2 overexpression leads to overproduction of endothelial tip cells by both morphologic and molecular criteria. Spatially localized overexpression of Edn2 produces a correspondingly localized endothelial response. Edn2 overexpression in the early embryo inhibits vascular development at midgestation, but Edn2 overexpression in developing skin and brain has no discernible effect on vascular structure. Inhibition of retinal angiogenesis by Edn2 requires expression of Endothelin receptor A but not Endothelin receptor B in the neural retina. Taken together, these observations imply that the neural retina responds to Edn2 by synthesizing one or more factors that promote the endothelial tip cell state and inhibit angiogenesis. The response to Edn2 is sufficiently potent that it overrides the activities of other homeostatic regulators of angiogenesis, such as Vegf.
Endothelin signaling is required for neural crest migration and homeostatic regulation of blood pressure. Here, we report that constitutive overexpression of Endothelin-2 (Edn2) in the mouse retina perturbs vascular development by inhibiting endothelial cell migration across the retinal surface and subsequent endothelial cell invasion into the retina. Developing endothelial cells exist in one of two states: tip cells at the growing front and stalk cells in the vascular plexus behind the front. This division of endothelial cell states is one of the central organizing principles of angiogenesis. In the developing retina, Edn2 overexpression leads to overproduction of endothelial tip cells by both morphologic and molecular criteria. Spatially localized overexpression of Edn2 produces a correspondingly localized endothelial response. Edn2 overexpression in the early embryo inhibits vascular development at midgestation, but Edn2 overexpression in developing skin and brain has no discernible effect on vascular structure. Inhibition of retinal angiogenesis by Edn2 requires expression of Endothelin receptor A but not Endothelin receptor B in the neural retina. Taken together, these observations imply that the neural retina responds to Edn2 by synthesizing one or more factors that promote the endothelial tip cell state and inhibit angiogenesis. The response to Edn2 is sufficiently potent that it overrides the activities of other homeostatic regulators of angiogenesis, such as Vegf.
T he architecture of the vertebrate vasculature has long been an object of fascination for biologists. At a macroscopic scale, the trajectories and branch points of major arteries and veins are highly stereotyped, and at a microscopic scale, capillary density within each tissue is governed by characteristic statistical parameters. These attributes are particularly accessible to observation and manipulation in the mammalian retina (1, 2) . In many mammals, including mice and humans, the retinal vasculature develops by radial migration of endothelial cells (ECs) along the inner (vitreal) face of the retina starting from their point of entry at the optic disk. In a second phase of development, branches from the primary vascular plexus penetrate into the retina to form two parallel tiers of capillaries that flank a central layer of retinal neurons, the inner nuclear layer (INL). During both phases, EC proliferation and migration are driven, at least in part, by tissue-derived Vegf (3, 4) .
During radial growth, there is a clear morphologic distinction between ECs at the growing front of the vascular plexus, referred to as tip cells, and the bulk of the ECs that follow behind the front, referred to as stalk cells (5) . In particular, tip cells possess numerous filopodia and are highly motile, acting like the vascular equivalent of axonal growth cones. Stalk cells proliferate, but they lack filopodia. The balance between tip and stalk cell states is orchestrated by asymmetric signaling through the Notch pathway: tip cells express the Notch ligand Δ-like4 (Dll4), which acts on stalk cell Notch receptors to decrease stalk-to-tip conversion, whereas stalk cells express the Notch ligand Jagged1, which antagonizes Dll4 activity (6, 7) . This pathway is intimately linked to Vegf signaling; Vegfa promotes Dll4 expression in tip cells, and Notch signaling in stalk cells suppresses the response to Vegfa. Additionally, Vegfa, acting through Vegfr2, directly promotes the tip cell fate, including filopodia formation. Recent time lapse imaging studies of vascular development in zebrafish and mammalian EC dynamics in explant culture show that the tip cell and stalk cell states are highly plastic, with frequent exchanges between the two cell states (8, 9) .
Several other signaling pathways are also essential for retinal vascular development. Norrin, a Muller-glia-derived ligand, and its EC receptor Frizzled4 (Fz4), coreceptor Lrp5, and receptor chaperone Tspan12 activate canonical Wnt signaling in developing ECs (10) . In humans and mice, defects in any of these components lead to retinal hypovascularization. Similar phenotypes are observed in mice lacking Angiopoietin2 (Ang2), an antagonist of the Tie2 receptor tyrosine kinase, or overexpressing leukemia inhibitory factor (11) (12) (13) .
Interest in retinal vascular development is motivated, in part, by the central role that neovascularization plays in age-related macular degeneration and diabetic retinopathy, two of the most prevalent adult-onset eye diseases (14) . The success of anti-Vegf therapies in treating these disorders has motivated the search for additional regulators of retinal vascular growth (15) .
The experiments reported here focus on the effects of endothelin signaling on retinal vascular development. Endothelins were initially discovered as endogenous vasoconstricting peptides (16) . In mammals, there are three closely related peptides [Endothelin-1 (Edn1), Edn2, and Edn3], each of which is encoded by a distinct gene and released by proteolysis from a large polypeptide precursor. Two G protein-coupled receptors, Ednra and Ednrb, mediate the effects of the endothelins. In addition to their roles in homeostatic regulation of blood pressureincluding regulation of arterial smooth muscle tone, renal fluid and salt retention, and cardiac contractility-endothelins and endothelin receptors play critical roles in neural crest migration (17) . In mice and humans, defects in Edn3 or Ednrb lead to Significance Two distinct and interconvertible types of endothelial cells are present during blood vessel growth: tip cells at the growing front of the vascular network and stalk cells behind the front. In the present study, overexpression of Endothelin-2, a peptide previously implicated in the control of blood pressure, is shown to promote the tip cell fate and arrest vascular growth within the mouse retina. Genetic experiments show that this effect requires Endothelin receptor A expression in the neural retina, implying the existence of a retina-derived regulator of vascular growth and development that is under Endothelin control.
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1315509110/-/DCSupplemental. deficiencies in skin melanocytes and enteric neurons in the colon, both of which are neural crest derivatives. In mice, defects in Edn1 or Ednra lead to deficiencies in cranial and cardiac neural crest derivatives, with resulting deficiencies in craniofacial and cardiac outflow tract development, respectively. Mutations in Edn2 have not been reported.
In earlier work, we and others identified Edn2 transcripts among a small set of transcripts that increase in abundance in injured or diseased photoreceptors (18) (19) (20) . This induction is observed in a wide variety of experimental paradigms, including retinal detachment, light damage, and inherited photoreceptor degeneration. Here we report the surprising discovery that Edn2 overexpression in the developing mouse retina potently and specifically inhibits retinal angiogenesis and promotes the tip cell state.
Results
Edn2 Overexpression in the Retina Inhibits Vascular Development.
Our point of departure for the experiments described below was the generation of a knockin mouse line at the Ubiquitinb locus that directs the expression of Edn2 from a CMV/β-actin (CAG) promoter after Cre-mediated excision of a loxP-stoploxP cassette (Fig. S1A ). With this allele, referred to as Z/Edn2, expression is possible in virtually any cell type and at any time during development, and is determined by the expression pattern of the Cre driver.
In Z/Edn2;Six3-Cre mice, Edn2 is produced throughout the developing and mature retina beginning at approximately embryonic day 11 (E11). An examination of adult Z/Edn2;Six3-Cre retinas revealed diverse morphologic defects (Fig. 1) . Some retinal regions are very thin, especially the ganglion cell layer and INL (compare Fig. 1A with Fig. 1B ) or less commonly, the outer nuclear layer (ONL) (Fig. 1C) . [Throughout this paper, control retinas are derived from age-matched and phenotypically WT mice-typically littermates-that carry a subset of the genetic markers of the experimental mice.] Other retinal regions exhibit extensive detachment, with numerous macrophages occupying the subretinal space, severe folding of the retina, accumulation of interstitial fluid, and/or development of interstitial fibrosis (Fig. 1 D-F) . In some regions, few or no blood vessels were observed on the vitreal face of the retina ( Fig. 1 B and C) , whereas in other regions, clusters of blood vessels occupy the vitreal face (Fig. 1D) . It is unclear whether these retina-associated vessels were initially derived from bona fide retinal vasculature or recruited from the hyaloid vasculature, a transient vascular plexus within the developing vitreous. Visualizing the vasculature with Griffonia simplicifolia (GS)-lectin binding confirmed these observations and also showed an absence of the normal intraretinal capillary beds in the IPL and OPL (compare Fig. 1G with Fig. 1H ).
To characterize vascular development in the Z/Edn2;Six3-Cre retina, we visualized ECs and astrocytes at different postnatal ages in flat-mount retinas (Fig. 2) . At postnatal day 3 (P3) and P6, the expanding front of the astrocyte network was modestly retarded in Z/Edn2;Six3-Cre retinas relative to littermate controls, but this differential disappeared by P8 (Fig. 2 A-E) . However, EC growth was significantly retarded in Z/Edn2;Six3-Cre retinas at all postnatal ages examined, with the radial position of the growing ECs largely arrested by ∼P6 (Fig. 2 A-E) . Despite their severely retarded radial migration, Z/Edn2;Six3-Cre ECs associate with astrocytes in a manner closely resembling control retinas (Fig. 2 F and G) . In adult Z/Edn2;Six3-Cre retinas, the density of mural cell coverage of the EC network is similar to controls, which was determined by immunostaining for NG2. The overall density of astrocytes and ECs in the vascularized territory of Z/Edn2;Six3-Cre retinas is several fold higher than in controls (Fig. 2 A-D) .
As noted in the Introduction, in the radially expanding early postnatal retinal vasculature, there are two morphologically and molecularly distinct classes of endothelial cells (5, 21) . Tip cells are located at the growing front, produce numerous filopodia, and lack a lumen. They also produce the paracrine ligand Apelin (Apln) and the Notch ligand Dll4, and they repress the Angiopoetin receptor Tie2. Stalk cells are located behind the growing front, lack filopodia, develop a luminal cavity, and form junctional complexes with neighboring stalk cells to create a capillary network; they express Tie2 but do not express Apln or Dll4. High-resolution imaging of P6 retinal flat mounts immunostained for the endothelial plasma membrane protein PECAM1 revealed the presence of filopodia-bearing ECs throughout much of the growing vascular plexus in Z/Edn2;Six3-Cre retinas, whereas control retinas show filopodia predominantly at the growing front ( Fig. 2 H and I) . A quantitative comparison of filopodial density in the interior of developing WT with Z/Edn2; Six3-Cre vascular networks is hampered by the higher mean density of ECs in the Z/Edn2;Six3-Cre plexus, which leaves far smaller cell-free spaces in which to observe the filopodia. With filopodia differentially scored based on their location at the vascular front or the interior, we observed a several fold higher density of filopodia in the interior of the Z/Edn2;Six3-Cre vascular plexus at P7 compared with the controls (Fig. S2) .
To measure the patency of the developing EC network, we used two methods. In the first method, we injected a small volume of highly concentrated Alexa595-GS-lectin into the beating hearts of deeply anesthetized mice (four Z/Edn2;Six3-Cre and five control mice at P5-P7). After waiting 5 min for the GS-lectin to fill and bind to the patent vasculature, the eyes were excised and fixed, and the isolated retinas were detergent-permeabilized. Then, the entire retinal vasculature was labeled with Alexa488-GS-lectin. In the second method, the circulatory system was perfused with DiI, a hydrophobic carbocyanine dye, through cardiac puncture and under external pressure (22) , after which the retinal vasculature was visualized by GS-lectin binding without detergent and promptly imaged (two Z/Edn2;Six3-Cre and three control mice at P7 and one Z/Edn2;Six3-Cre and one control at P11). Fig. 3 shows that, in control retinas, the perfused fluorescent reporters label the vascular plexus uniformly and within one to three cell diameters of the growing front. In contrast, in Z/Edn2;Six3-Cre retinas, perfusion is limited to a territory that is 5-15 cell diameters behind the growing vascular front and is spatially heterogeneous. In keeping with this perfusion deficit, tissue hypoxia-as measured by the accumulation of pimonidazole (Hypoxyprobe) (23)-was substantial in the Z/Edn2;Six3-Cre retina, both in front of and beneath the developing vascular plexus (Fig. 3 F and G). To extend the morphologic and functional analyses described in the preceding section to the molecular level, we compared transcript abundances and localizations in control versus Z/Edn2; Six3-Cre retinas. These analyses were performed on P5-P8 retinas during the period of rapid endothelial growth. At P6 there are large numbers of patent vessels at the vitreal surface of the control retina, with larger vessels overlying the central retina and smaller vessels overlying the peripheral retina (Fig. 4A , Left). In keeping with the data shown in Figs. 2 and 3, near the center of the Z/Edn2;Six3-Cre retina, there are both patent vessels and masses of ECs without luminal spaces (Fig. 4A , Upper Right), whereas in the peripheral retina, ECs are entirely absent from the vitreal surface (Fig. 4A , Lower Right). The peripheral Z/Edn2; Six3-Cre retina is also thinner than the control at P6.
Whole-retina transcriptome analyses were performed using both microarray hybridization at P8 and RNAseq at P5; the two methods gave largely congruent results ( Fig. 4 B and C and Tables S1-S4). Based on the histologic analyses described above, we expect transcriptome differences to reflect a combination of the following perturbations in the Z/Edn2;Six3-Cre retina: (i) Edn2-mediated regulation of gene expression in the retina and/ or vasculature, (ii) retinal hypoxia, and (iii) excess of tip cells. As expected, Edn2 coding sequences were present at far higher abundances (∼100-fold) in Z/Edn2;Six3-Cre compared with control retina, which was determined by RNAseq. (No differences in Edn2 transcript abundance were registered in the microarray analysis, because all of the Edn2 oligonucleotide probe sets in the Affimetrix version 430 2.0 gene chip are derived from the Edn2 3′ UTR, which was not included in the Z/Edn2 knockin.) More interestingly, the stalk cell markers Tie2 and Apj (the G protein-coupled receptor for Apln) were underrepresented in the Z/Edn2;Six3-Cre retina transcriptome as were the transporters Slco1c1 and Slc38a5 (mediators of thyroid hormone and neutral amino acid uptake, respectively) and transcription factor Sox17, which was suggested by earlier work to be a regulator of retinal vascular development in response to Norrin/Fz4 signaling (24) . The tip cell markers Apln and Esm1 (21, 25) were overrepresented in the Z/Edn2;Six3-Cre retina transcriptome along with Vegfa, which was expected for an hypoxic retina (Fig. 4 B and C). The abundances of several other transcripts, including potassium channel Kcne3 transcripts, were also substantially increased. The failure to observe statistically significant enrichment of other tip cell transcripts in our Z/Edn2;Six3-Cre transcriptome analyses may reflect the use of whole retina rather than purified ECs as the starting material. The spatial distributions of several of these differentially regulated transcripts were analyzed by in situ hybridization to crosssections and flat mounts of P6 eyes (Fig. 4 D-O) . In control eyes, Apln transcripts are localized to a thin annulus of tip cells at the growing vascular front, whereas in Z/Edn2;Six3-Cre retinas, they are distributed over the outer one-half of the thickened donutshaped vascular plexus as well as in a dispersed set of cells beyond the vascular front, possibly a subset of astrocytes (Fig. 4 D  and L) . In cross-sections of the midcentral retina, Dll4 and Ang2 transcripts, both of which are normally enriched in tip cells (21) , are present at the vitreal face of Z/Edn2;Six3-Cre but undetectable in the corresponding region of control retinas (Fig. 4  E and F) . In flat mounts of control retinas, Dll4 transcripts are localized to tip cells, whereas in Z/Edn2;Six3-Cre retinas, Dll4 transcripts are seen throughout the thickened vascular plexus (Fig.  4K) . Apj transcripts, which are localized to veins and mature capillaries in control retinas, are confined to a sparsely vascularized central territory in Z/Edn2;Six3-Cre retinas and excluded from the surrounding mass of ECs (Fig. 4M) . Plexin-D1 transcripts, which are enriched at the vascular front in control retinas (26) , and Kcne3 transcripts, which localize to tip cells in control retinas, are both found throughout the thickened vascular plexus in Z/Edn2;Six3-Cre retinas (Fig. 4 N and O) .
During normal ocular development, astrocytes ahead of the radially expanding vascular plexus express Vegfa (2). After the vitreal face of the retina has been vascularized, cells within the INL, particularly Muller glia, serve as the principle source of Vegfa. At P6, Vegfa transcripts in Z/Edn2;Six3-Cre retinas are up-regulated in both the INL and astrocytes (Fig. 4G, Right) . The endothelial localization of Apln transcripts and the periendothelial localization of Vegfa transcripts are shown in retina cross-sections (Fig. 4 H and I) . At P6, control retinas show Vegf transcripts both in front of the growing vasculature and within circumscribed territories bounded by arteries and arterioles in the more mature central retina (Fig. 4 J) . In contrast, Z/Edn2;Six3-Cre retina flat mounts show Vegf transcripts at uniformly high abundance throughout the central retina (Fig. 4 J) . In Z/Edn2;Six3-Cre retinas, the high levels of Vegfa expression by astrocytes that are in intimate contact with nonperfused ECs argue that, during normal retinal vascular development, repression of astrocyte-derived Vegfa is not caused by direct EC-astrocyte contact but rather by the increased astrocyte oxygenation that accompanies the radial expansion of a perfused vasculature. The data also show that the block to vascular growth in Z/Edn2;Six3-Cre retinas is not caused by a lack of Vegfa but, on the contrary, occurs despite elevated Vegfa.
To summarize the experiments up to this point, early panretinal expression of Edn2 produces a large excess of tip cells within the growing vasculature; however, these cells do not spread radially beyond the central retina, and they do not invade the retina, despite high levels of local (astrocyte) and intraretinal (INL) Vegfa expression.
Low Levels of Edn2 Generate Interstitial Tip Cells in the Mature
Retinal Vasculature. Because the Six3-cre driver recombines target genes in all retinal neurons and glia, including astrocytes (as determined by crossing it to a reporter line) (Fig. S3A) (27) , we wondered whether less complete recombination of the Z/Edn2 target might lead to a milder vascular phenotype and permit an assessment of Edn2 effects in the context of a minimally perturbed retinal vascular architecture. To achieve this goal, we studied Z/Edn2;PDGFRα-Cre mice, in which recombination of the Z/Edn2 target peaks at ∼30% of retinal cells, which was measured using Z/H2B-GFP, a reporter identical in all respects to Z/Edn2 except for the replacement of Edn2 by histone H2B-GFP coding sequences (Fig. S4A) . The Z/Edn2;PDGFRα-Cre retina closely resembles the WT control with respect to thickness, lamination, and vascular architecture (Fig. S4B) . However, close inspection of GS-lectin-stained adult retina cross-sections shows that intraretinal capillaries are larger and more numerous in Z/Edn2;PDGFRα-Cre retinas compared with controls, an im- 
approximately twofold increase in hybridization intensity and P values < 0.05. In situ hybridization for these two transcripts is shown in D and G. Because of the presence of nonspecific background signal, microarray hybridization intensity changes typically underestimate the actual fold change in RNA abundance. (C) Expression profiling using RNAseq. The data presented is from a single sequencing experiment with RNA from P5 control and Z/Edn2;Six3-Cre retinas. The ratio (on a log 2 scale) of read counts for individual transcripts from control vs. Z/Edn2;Six3-Cre libraries is shown for all genes with more than twofold ratios (i.e., log 2 > 1) and P values < 0.05. Transcripts highlighted in B are highlighted here. (D-I) In situ hybridization to retina sections from P6 control and Z/Edn2;Six3-Cre retinas. Probes for tip cell markers are (D) Apln, (E) Dll4, and (F) Ang2. In D, Apln transcripts are present only on the vitreal face of the retina. They are localized to a narrow annulus of tip cells in the periphery of the control retina (bracket in boxed region enlarged in Inset in D, Left) but broadly distributed in surface ECs near the center of the Z/Edn2;Six3-Cre retina (D, Right). E-I show sections of central retina. In E, Dll4 transcripts are not detectable in the control retina but localize to ECs on the vitreal surface of the Z/Edn2;Six3-Cre retina. In F, Ang2 transcripts are present in a subset of cells in the INL (probably horizontal cells) in both control and Z/Edn2;Six3-Cre retinas; Ang2 transcripts are absent from ECs in the control retina and present in ECs on the vitreal surface of the Z/Edn2; Six3-Cre retina. In G, Vegfa transcripts are present in the retinal pigment epithelium (RPE) and INL in both control and Z/Edn2;Six3-Cre retinas (with a stronger INL signal in the latter); Vegfa transcripts are not detected on the vitreal surface of the control retina but are abundant in astrocytes in Z/Edn2;Six3-Cre retinas. In H and I, GS-lectin staining after in situ hybridization to Z/Edn2;Six3-Cre retinas shows (H) Apln transcripts colocalizing with GS-lectin in ECs and (I) Vegfa transcripts in astrocytes interdigitating with ECs. ISH, in situ hybridization. (Scale bars: D, 500 μm; E-G, 100 μm; H and I, 50 μm.) (J-O) In situ hybridization to retina flat mounts from P6 control and Z/Edn2;Six3-Cre retinas. Green, GS-lectin; red, in situ hybridization signal. Boxed regions are enlarged as Insets. The in situ hybridization signal in H-O and Fig. 6A consists of purple alkaline phosphatase reaction product; it has been false colored red for illustrative purposes. (Scale bar: 500 μm.) PlxnD1, Plexin-D1.
pression confirmed by quantification of OPL capillary density, which showed an ∼15% difference in density (Fig. 5C) . In situ hybridization shows a small elevation in the levels of Vegfa transcripts in the Z/Edn2;PDGFRα-Cre INL, especially in regions >10-15 μm from a capillary (Fig. S4B) .
The data described in the preceding paragraph imply that Z/Edn2;PDGFRα-Cre retinas have a modest defect in INL perfusion, despite an elevated capillary density. The resolution to this apparent paradox is that Z/Edn2;PDGFRα-Cre retinas have large numbers of capillaries that terminate with blind endings, an architecture that was not observed in either phenotypically normal control retinas or retinas with underdeveloped OPL and IPL capillary beds (Fig. 5 A and B) . [The latter retinas were generated by artificially delaying the expression of the Fz4 ligand Norrin in a genetic background in which the gene coding for Norrin (Ndp) was mutated (Ndp KO ;Z/Norrin;Glast-CreER) (figure 7 in ref. 28 ).] The blind endings were most numerous in the IPL, with ∼200 per retina. Blind endings were typically decorated with multiple filopodia, and immunostaining for the stalk cell marker Tie2 showed that, unlike the bulk of the intraretinal capillary network, the blind endings were selectively depleted for Tie2 (Fig. 5A) . A comparison of the number of blind endings at P12, P13, P20, and P28 in control retinas (n = 30) with Z/Edn2; PDGFRα-Cre retinas (n = 20) shows (i) that blind endings are present in immature retinas of both genotypes and are most abundant in the IPL and (ii) that blind endings are largely eliminated from control but not from Z/Edn2;PDGFRα-Cre retinas by P28.
These data indicate that the mature Z/Edn2;PDGFRα-Cre retinal vasculature harbors large numbers of tip cells embedded within an otherwise normal vascular architecture. We presume that hypoperfusion of the blind endings contributes to tissue hypoxia, which in turn, leads, through Vegfa signaling, to the observed increase in vascular density. However, the presence of filopodia bearing ECs cannot be ascribed simply to tissue hypoxia and/or elevated levels of Vegfa, because Ndp KO ;Z/Norrin; Glast-CreER retinas exhibit similar or greater levels of hypoxia but do not develop interstitial tip cells (28) .
Spatial Localization of Edn2 Action. The experiments described thus far involve relatively uniform Z/Edn2 activation across the retina. We thought it would be of interest to determine the effect on retinal vascular development of a spatially defined pattern of Z/Edn2 activation. Because vascular growth begins at the optic disk, the simplest experimental design would be one in which Z/Edn2 is activated exclusively in the peripheral retina, and therefore, the growing vasculature could be studied as it passes from a territory with little or no Edn2 to one with excess Edn2. To effect this experimental design, we used a Pax6-α-Cre driver, because this transgene recombines target genes in all retinal layers beginning at ∼E11 but only in the nasal and temporal ∼50% of the retina (29) . Using a reporter, recombination is observed in all retinal neurons and Muller glia but not in astrocytes (Fig. S3B) . The Z/Edn2;Pax6-α-Cre retinal architecture is close to normal in the central retina, with three vascular layers and only irregular pockets of Vegfa expression in the INL (Fig. 6A, Left) . However, in the peripheral Z/Edn2;Pax6-α-Cre retina, intraretinal capillaries were rarely observed, there was massive induction of Vegfa in the INL, and as observed in Z/Edn2;Six3-Cre retinas, there was thinning of all three retinal layers (Fig. 6A, Right) .
Direct measurements of tissue hypoxia by immunostaining for Hypoxyprobe in retinal cross-sections showed little accumulation in the INL of the central Z/Edn2;Pax6-α-Cre retina but substantial accumulation in the INL of the peripheral retina, especially in those territories farthest removed from a blood vessel (Fig. 6A, Lower) . Flat-mount imaging confirmed this trend, showing a pattern of Hypoxyprobe accumulation in irregularly shaped territories that were bounded by narrow perivascular bands of Hypoxyprobe-negative retina (Fig. 6B) .
The block to vascular growth in the periphery of the Z/Edn2; Pax6-α-Cre retina creates a sharp boundary between the fully vascularized central retina and the completely avascular peripheral retina. Just proximal to the arrested front, the adult retinal vasculature looks essentially normal, but at the front, there are numerous filopodia-bearing and Tie2-negative ECs (i.e., a layer of tip cells ahead of a plexus of stalk cells) (Fig. 6C) . The simplest explanations for this arrangement are that Edn2-expressing retinal tissue favors the tip cell state while blocking tip cell migration and that this spatial arrangement of tip and stalk cell states can persist into adulthood. Because tip cells are only seen at the vascular front in Z/Edn2;Pax6-α-Cre retinas, it seems that locally synthesized Edn2 and its effectors (discussed below) exhibit little diffusion across the retina.
Vascular Effects of Edn2 Are Mediated by Retinal Neurons and/or Glia via Ednra Signaling. The experiments described thus far have not defined the cell types that serve as the proximal sites of Edn2 action. The simplest model would be one in which retina-derived Edn2 acts directly on the growing vasculature, but it is also possible that Edn2 acts on nonvascular cells, which then signal secondarily to ECs. To distinguish between these possibilities, we used the Pax6-α-Cre driver to both activate Z/Edn2 and eliminate either of the two endothelin receptors in the peripheral retina. For this purpose, we constructed a mouse line carrying a conditional null allele of Ednrb (Ednrb f ) (Fig. S1B) , and we used a previously described Ednra f line (30) . Because Pax6-α-Cre is active in the neural retina but not in the vasculature or astrocytes (Fig. S3B) ). Littermates carrying Ednra f/+ or Ednrb f/+ served as controls. Fig. 7A shows the result of Ednra or Ednrb elimination. The adult retina flat mounts show the trilayered vasculature (color coded by depth) as well as the boundary between Cre-recombined and -nonrecombined retinal territories. This boundary can be precisely defined, because the Z/Edn2 allele includes the coding region for a β-gal reporter within the loxP-stop-loxP cassette, and therefore, β-gal is produced by cells lacking Cre and is eliminated from cells expressing Cre. As seen in the control Z/Edn2;Pax6-α-Cre;Ednrb f/+ retina, the two intraretinal vascular beds occupy a territory that closely matches the territory of β-gal expression (Fig. 7A, Left) . The hypertrophic surface vasculature continues for a variable distance beyond this border. By contrast, elimination of Ednra in the retina (genotype Z/Edn2;Pax6-α-Cre; Ednra f/− ) leads to growth of all three vascular layers beyond the Cre-recombined territory, whereas loss of Ednrb in the retina (genotype Z/Edn2;Pax6-α-Cre;Ednrb f/− ) leads to truncation of the two intraretinal vascular layers several hundred micrometers short of the edge of the Cre-recombined territory, with variable growth of the surface vasculature beyond that point (Fig. 7A , Center and Right).
These phenotypes were quantified by measuring total retinal area and the fraction of the retinal plane that is vascularized for Z/Edn2;Pax6-α-Cre;Ednra , and Z/Edn2;Pax6-α-Cre;Ednrb f/+ retinas ( Fig.  7 B and C) . This analysis shows that elimination of Ednra in retinal neurons and glia results in a nearly complete rescue of the vascular truncation phenotype. In contrast, elimination of Ednrb in retinal neurons and glia seems to sensitize the vasculature to Edn2-mediated inhibition, as determined by the arrest of vascular growth proximal to the front of Cre-mediated recombination (Fig. 7A ) and the smaller total area of vascularized retina (Fig. 7 B and C) . This last observation could be explained if Ednra and Ednrb act antagonistically or if loss of Ednrb leads to a compensatory upregulation of Ednra or a sensitization of its signaling pathway.
Tissue and Developmental Stage Specificity of the Antiangiogenic
Effects of Edn2. The phenotypic analyses described thus far were confined to the retina, and thus, they do not address whether Edn2-dependent inhibition of vascular growth is observed in other tissues. To the best of our knowledge, the expression of the Pax6-α-Cre is confined to the retina, but Six3-Cre is also expressed in the embryonic forebrain (31), and PDGFRα-Cre expression would be expected in a wide variety of tissues (32) . The postnatal viability and grossly normal health of Z/Edn2; Six3-Cre and Z/Edn2;PDGFRα-Cre mice argue against a severe Edn2-mediated inhibition of extraretinal vascular development in these two lines. To test the effect of Edn2 overexpression at the beginning of vascular development, Z/Edn2 was combined with Sox2-Cre, a transgene that expresses Cre throughout the early embryo. As shown in Fig. 8 A-F and Table 1 , Z/Edn2; Sox2-Cre embryos recovered at E8.5 were mildly growth-retarded, but Z/Edn2;Sox2-Cre embryos recovered at E9.5-E10.5 were severely retarded and displayed an open neural tube, an enlarged heart, and pooled blood in the head and thorax. Strikingly, flatmount immunostaining for PECAM1 showed a nearly complete absence of vascular development in E9.5 Z/Edn2;Sox2-Cre embryos (Fig. 8 G and H) . Z/Edn2-dependent growth retardation during fetal life could be suppressed in ∼20% of late-gestation embryos by eliminating Ednra but not Ednrb (Fig. 8J and Table 1 ). In fact, the ∼20% figure is a substantial underestimate of the Ednra effect, because among the Sox2-Cre;Ednra f/− littermates of the Z/Edn2;Sox2-Cre;Ednra f/− embryos, the loss of Ednra alone resulted in only ∼20% survival to late gestation. The phenotypic rescue conferred by mutation of Ednra shows that, in the embryo (like in the retina), overexpression of Edn2 does not produce nonspecific toxicity but rather, exerts its effect by engaging one of its two high-affinity receptors.
To extend the testing of Edn2 overexpression to later times and additional tissues, we examined the vasculature in Z/Edn2; K5-Cre and Z/Edn2;Foxg1-Cre mice, in which Cre production begins at or shortly after midgestation in the epidermis (33) and before midgestation in the head, respectively (34) . Sections of postnatal skin from Z/Edn2;K5-Cre mice and late-gestation brains from Z/Edn2;Foxg1-Cre fetuses show vascular architecture indistinguishable from normal littermate controls (Figs. S5 and  S6) . In X-Gal-stained sections through the external ear, control Z/Edn2 mice produce β-gal in the epidermis from the unrecombined Z/Edn2 locus, control K5-Cre mice show no β-gal in the epidermis, and Z/Edn2;K5-Cre mice show both a loss of epidermal β-gal and a massive increase in dermal pigmentation (Fig.   S5 ). The increase in pigmentation is the expected result of Ednrb hyperactivation in melanocyte precursors (35, 36) , and it serves as an internal control for the production of bioactive Edn2. An analogous internal control is observed in Z/Edn2;Foxg1-Cre mice, where excess Edn2 production in the head results in a failure to close the palate and eyelids; the former defect produces early postnatal lethality (Fig. S6) .
Taken together, these data show that the antiangiogenic effects of Edn2 are far from universal, despite the expression of Ednra and Ednrb in a wide range of cell types, including neurons, keratinocytes, adipocytes, and smooth muscle cells (17) . Indeed, even closely related tissues, such as brain and retina, differ markedly in their response to Edn2.
Edn Signaling in the Normal Retina: Genetic Loss-of-Function
Experiments. All of the experiments described thus far involve overexpression of Edn2. If endothelin signaling plays a nonredundant role in normal retinal vascular development or homeostasis, one would expect that loss of endothelin signaling would produce defects in vascular architecture. To test this prediction, we generated a conditional null allele of Edn2 (Fig.  S1C) . Edn2 ;Six3-Cre mice. Because Edn1 (which activates Ednra and Ednrb) and/or Edn3 (which activates Ednrb) could be compensating for loss of Edn2, we also studied vascular architecture in neural retina-specific Ednr KOs: Ednra f/− ;Six3-Cre, Ednrb f/− ;Six3-Cre, and Ednra f/f ; Ednrb f/f ;Six3-Cre. All have normal vascular architecture. Assuming that the Cre recombinase eliminated all four conditional alleles in the double receptor conditional KO, this experiment shows that endothelin signaling by retinal neurons and glia is dispensable for normal vascular development. Taken together, these experiments imply that, in mice, any role that endothelin signaling plays in normal retinal vascular development is redundant with other signaling systems.
Discussion
The principle results of this study are that (i) overexpression of Edn2 in the mouse retina leads to an excess of tip cells and inhibition of vascular growth, effects that require Ednra but not Ednrb signaling in retinal neurons and/or glia; (ii) overexpression of Edn2 has no effect on vascular architecture in the brain or skin, but it arrests vascular development in the midgestation embryo; and (iii) loss of Ednra and/or Ednrb in the retina has little or no effect on normal vascular development. Although the tip cell overproduction/stabilization phenotype described here is reminiscent of the phenotype seen after EC-specific deletion of Vegfr-3 or suppression of Notch signaling (6, 37, 38) , it is conceptually distinct in that it is induced by genetic manipulations of retinal neurons and glia rather than ECs.
Implications for Tip Vs. Stalk Cell States. As noted above, Notch and Vegfr-3 signaling in ECs controls the balance between tip and stalk cell states. Notch signaling is largely intrinsic to the vasculature, reflecting tip vs. stalk cell production of ligands Dll4 and Jagged1 and their relative occupancies of Notch receptors on the same cells (6, 39) . Vegfa signaling integrates EC growth with tissue hypoxia: a gradient of Vegfa guides tip cell migration, and the absolute levels of Vegfa determine stalk cell proliferation (3). Cross-regulation between the two signaling systems occurs through Vegf-dependent regulation of Notch signaling and Notch regulation of Vegfr-3 levels (37, 38) . Notch/Vegf cross-regulation also involves other signaling systems; Vegfa induces plexin-D1 expression by tip cells, and the resulting Sema-3E/Plexin-D1 signal represses Notch signaling (26) . For each cross, the expected number of embryos is determined by the genotypic class that has no perturbation or the most minimal perturbation in endothelin signaling components.
Can the effects of Edn2 overexpression be understood within the existing framework of EC development? The simplest hypothesis is that Edn2 acting on retinal neurons and/or glia causes the production of one or more factors that arrest vascular migration and invasion. The resulting tissue hypoxia leads to up-regulation of astrocyte-and retina-derived Vegfa, which promotes both the tip cell state and stalk cell proliferation. Although this model accounts for some of the data, it does not explain the persistence of occasional tip cells within the mature retinal vasculature of Z/Edn2;PDGFRα-Cre mice. This model also does not account for the observation that other mutant retinas with impaired vascular growth and elevated levels of Vegfa (e.g., Ndp KO and Ndp KO ;Z/Norrin;Glast-CreER) do not exhibit an excess of tip cells (Fig. 5) (28) .
Properties of the Tissue Mediator(s) of Endothelin Effects on Vascular
Development. The production of excess tip cells in the context of increased endothelin signaling suggests that retinal neurons and/ or glia produce a tip cell factor (or factors) and that this factor is distinct from Vegfa. Whether a single factor or multiple factors account for both the excess of tip cells and the block to EC migration and invasion is unknown. It is also unclear whether such activities derive from cell-associated or -secreted factor(s). If the factor is secreted, the sharp boundary of EC invasion and growth inhibition seen in Z/Edn2;Pax6-α-Cre retinas argues that its diffusion is limited. The failure to observe a vascular phenotype when the developing brain and epidermis are exposed to Edn2 (in Z/Edn2;Foxg1-Cre and Z/Edn2;K5-Cre mice, respectively) implies that the brain and epidermis differ from the retina in their response to endothelin or their intrinsic capacity to produce the migration/invasion blocking factor(s).
One of the most striking features of the Edn2 overexpression phenotype is its ability to override the normal homeostatic mechanisms that control retinal vascular development, including Vegfa-induced migration and invasion. This effect is especially striking, because in these experiments, ECs were not subject to genetic manipulation. Based on the potency of its effects, the data suggest that this undefined mode of communication between the neural retina and the vasculature may be a major regulator of vascular growth and development.
Clinical Implications. In Z/Edn2;PDGFRα-Cre mice, the presence of interstitial tip cells in what is otherwise a nearly normal retinal vasculature implies that many or all adult capillary ECs retain the capacity to transition to a tip cell state. Such a capacity may be relevant to the initiation of neovascular growth, which is seen in diabetic retinopathy or retinopathy of prematurity. If, as suggested here, the retina produces one or more tip cell factors and if such factors could be identified, it would be of great interest to explore their roles in diseases associated with pathologic neovascularization.
Methods
Gene targeting, mouse husbandry, RNAseq, microarray hybridization, in situ hybridization, histochemistry, immunostaining, labeling of patent blood vessels, Hypoxyprobe analysis, and quantification of retinal vascular coverage are described in SI Methods.
